0.011784
0.000000
0.000000
0.000000
0.011784
0.000000
0.000000
0.000000
0.018954
0.00000
0.00000
0.00000
Lubkowski, J.
Bujacz, G.
Boque, L.
Wlodawer, A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
16
90.00
90.00
90.00
84.860
84.860
52.760
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
4
64
69
10.1038/nsb0197-64
8989326
The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions.
1997
US
Biochemistry
BICHAW
0033
0006-2960
35
6569
Heteronuclear (1H, 13C, 15N) NMR Assignments and Solution Structure of the Monocyte Chemoattractant Protein-1 (Mcp-1) Dimer
1996
10.2210/pdb1dol/pdb
pdb_00001dol
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
298
1
COLLIMATOR
IMAGE PLATE
1995-09-11
MARRESEARCH
GRAPHITE(002)
M
x-ray
1
1.5418
1.0
1.5418
ROTATING ANODE
RIGAKU RUH2R
8830.239
MONOCYTE CHEMOATTRACTANT PROTEIN 1
INS(MET0)
1
man
polymer
18.015
water
52
nat
water
MCP-1, MCAF
no
no
MQPDAINAPVTCCYNFTNRKISVQRLASYRRITSSKCPKEAVIFKTIVAKEICADPKQKWVQDSMDHLDKQTQTPKT
MQPDAINAPVTCCYNFTNRKISVQRLASYRRITSSKCPKEAVIFKTIVAKEICADPKQKWVQDSMDHLDKQTQTPKT
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
BL21
1
2.8
56.
INITIAL MODEL FOR MOLECULAR REPLACEMENT WAS MODIFIED AS DESCRIBED IN JOURNAL ARTICLE.
VAPOR DIFFUSION, HANGING DROP
8.0
10 MG/ML PROTEIN IN 50 MM TRIS BUFFER PH 7.5-8 EQUILIBRATED AGAINST 50-55% AMMONIUM SULFATE USING HANGING DROP VAPOR DIFFUSION METHOD., pH 8.0, vapor diffusion - hanging drop
7.5-8.0
database_2
pdbx_initial_refinement_model
repository
Initial release
Version format compliance
Derived calculations
Version format compliance
Database references
Refinement description
1
0
1997-03-12
1
1
2008-03-24
1
2
2011-07-13
1
3
2023-08-09
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
Y
BNL
1996-11-22
REL
HOH
water
RESIDUE MET 0 IS AN ARTIFACT OF EXPRESSION.
1DOM
PDB ENTRY 1DOM
PDB
experimental model
HOH
201
2
HOH
HOH
201
A
HOH
202
2
HOH
HOH
202
A
HOH
203
2
HOH
HOH
203
A
HOH
204
2
HOH
HOH
204
A
HOH
205
2
HOH
HOH
205
A
HOH
206
2
HOH
HOH
206
A
HOH
207
2
HOH
HOH
207
A
HOH
208
2
HOH
HOH
208
A
HOH
209
2
HOH
HOH
209
A
HOH
210
2
HOH
HOH
210
A
HOH
211
2
HOH
HOH
211
A
HOH
212
2
HOH
HOH
212
A
HOH
213
2
HOH
HOH
213
A
HOH
214
2
HOH
HOH
214
A
HOH
215
2
HOH
HOH
215
A
HOH
216
2
HOH
HOH
216
A
HOH
217
2
HOH
HOH
217
A
HOH
218
2
HOH
HOH
218
A
HOH
219
2
HOH
HOH
219
A
HOH
220
2
HOH
HOH
220
A
HOH
221
2
HOH
HOH
221
A
HOH
222
2
HOH
HOH
222
A
HOH
223
2
HOH
HOH
223
A
HOH
224
2
HOH
HOH
224
A
HOH
225
2
HOH
HOH
225
A
HOH
226
2
HOH
HOH
226
A
HOH
227
2
HOH
HOH
227
A
HOH
228
2
HOH
HOH
228
A
HOH
229
2
HOH
HOH
229
A
HOH
230
2
HOH
HOH
230
A
HOH
231
2
HOH
HOH
231
A
HOH
232
2
HOH
HOH
232
A
HOH
233
2
HOH
HOH
233
A
HOH
234
2
HOH
HOH
234
A
HOH
235
2
HOH
HOH
235
A
HOH
236
2
HOH
HOH
236
A
HOH
237
2
HOH
HOH
237
A
HOH
238
2
HOH
HOH
238
A
HOH
239
2
HOH
HOH
239
A
HOH
240
2
HOH
HOH
240
A
HOH
241
2
HOH
HOH
241
A
HOH
242
2
HOH
HOH
242
A
HOH
243
2
HOH
HOH
243
A
HOH
244
2
HOH
HOH
244
A
HOH
245
2
HOH
HOH
245
A
HOH
246
2
HOH
HOH
246
A
HOH
247
2
HOH
HOH
247
A
HOH
248
2
HOH
HOH
248
A
HOH
249
2
HOH
HOH
249
A
HOH
250
2
HOH
HOH
250
A
HOH
251
2
HOH
HOH
251
A
HOH
252
2
HOH
HOH
252
A
MET
0
n
1
MET
0
A
GLN
1
n
2
GLN
1
A
PRO
2
n
3
PRO
2
A
ASP
3
n
4
ASP
3
A
ALA
4
n
5
ALA
4
A
ILE
5
n
6
ILE
5
A
ASN
6
n
7
ASN
6
A
ALA
7
n
8
ALA
7
A
PRO
8
n
9
PRO
8
A
VAL
9
n
10
VAL
9
A
THR
10
n
11
THR
10
A
CYS
11
n
12
CYS
11
A
CYS
12
n
13
CYS
12
A
TYR
13
n
14
TYR
13
A
ASN
14
n
15
ASN
14
A
PHE
15
n
16
PHE
15
A
THR
16
n
17
THR
16
A
ASN
17
n
18
ASN
17
A
ARG
18
n
19
ARG
18
A
LYS
19
n
20
LYS
19
A
ILE
20
n
21
ILE
20
A
SER
21
n
22
SER
21
A
VAL
22
n
23
VAL
22
A
GLN
23
n
24
GLN
23
A
ARG
24
n
25
ARG
24
A
LEU
25
n
26
LEU
25
A
ALA
26
n
27
ALA
26
A
SER
27
n
28
SER
27
A
TYR
28
n
29
TYR
28
A
ARG
29
n
30
ARG
29
A
ARG
30
n
31
ARG
30
A
ILE
31
n
32
ILE
31
A
THR
32
n
33
THR
32
A
SER
33
n
34
SER
33
A
SER
34
n
35
SER
34
A
LYS
35
n
36
LYS
35
A
CYS
36
n
37
CYS
36
A
PRO
37
n
38
PRO
37
A
LYS
38
n
39
LYS
38
A
GLU
39
n
40
GLU
39
A
ALA
40
n
41
ALA
40
A
VAL
41
n
42
VAL
41
A
ILE
42
n
43
ILE
42
A
PHE
43
n
44
PHE
43
A
LYS
44
n
45
LYS
44
A
THR
45
n
46
THR
45
A
ILE
46
n
47
ILE
46
A
VAL
47
n
48
VAL
47
A
ALA
48
n
49
ALA
48
A
LYS
49
n
50
LYS
49
A
GLU
50
n
51
GLU
50
A
ILE
51
n
52
ILE
51
A
CYS
52
n
53
CYS
52
A
ALA
53
n
54
ALA
53
A
ASP
54
n
55
ASP
54
A
PRO
55
n
56
PRO
55
A
LYS
56
n
57
LYS
56
A
GLN
57
n
58
GLN
57
A
LYS
58
n
59
LYS
58
A
TRP
59
n
60
TRP
59
A
VAL
60
n
61
VAL
60
A
GLN
61
n
62
GLN
61
A
ASP
62
n
63
ASP
62
A
SER
63
n
64
SER
63
A
MET
64
n
65
MET
64
A
ASP
65
n
66
ASP
65
A
HIS
66
n
67
HIS
66
A
LEU
67
n
68
LEU
67
A
ASP
68
n
69
ASP
68
A
LYS
69
n
70
LYS
69
A
GLN
70
n
71
GLN
70
A
n
72
71
A
n
73
72
A
n
74
73
A
n
75
74
A
n
76
75
A
n
77
76
A
author_defined_assembly
1
monomeric
software_defined_assembly
PISA,PQS
4
tetrameric
6690
-34
15220
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
8_666
-y+1,-x+1,-z+1
crystal symmetry operation
84.8600000000
84.8600000000
52.7600000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
10_665
-x+1,-y+1,z
crystal symmetry operation
84.8600000000
84.8600000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
15_556
y,x,-z+1
crystal symmetry operation
0.0000000000
0.0000000000
52.7600000000
A
O
ILE
51
A
O
ILE
52
A
N
PHE
43
A
N
PHE
44
A
O
ALA
40
A
O
ALA
41
A
N
ILE
31
A
N
ILE
32
1
A
HOH
222
B
HOH
1
A
HOH
225
B
HOH
1
A
HOH
240
B
HOH
1
A
HOH
241
B
HOH
1
A
HOH
245
B
HOH
1
A
THR
71
A
THR
72
1
Y
1
A
GLN
72
A
GLN
73
1
Y
1
A
THR
73
A
THR
74
1
Y
1
A
PRO
74
A
PRO
75
1
Y
1
A
LYS
75
A
LYS
76
1
Y
1
A
THR
76
A
THR
77
1
Y
1
A
PRO
2
-77.37
-79.99
PARHCSDX.PRO
TOPHCSDX.PRO
TOPH19.PEP
19.6
0.275
0.017
0.2
0.2
2.4
10.0
260
3309
7.0
84.5
RANDOM
1000000.0
0.01
1
2.0
MOLECULAR REPLACEMENT
PDB ENTRY 1DOM
2.4
10.0
52
620
0
0
568
0.015
1.78
28.3
1.51
0.942
4.0
0.975
5.0
0.942
4.5
0.975
5.5
2.4
40.0
1DOL
3573
0.0
0.1
1
8.1
2.41
87.9
2.40
2.49
2.62
0.267
1
2.20
82.2
data reduction
DENZO
data scaling
SCALEPACK
phasing
AMoRE
refinement
X-PLOR
3.1
MONOCYTE CHEMOATTRACTANT PROTEIN 1, I-FORM
1
N
N
2
N
N
A
ALA
4
A
ALA
5
HELX_P
A
ASN
6
A
ASN
7
5
1
3
A
VAL
22
A
VAL
23
HELX_P
A
ARG
24
A
ARG
25
5
2
3
A
LYS
58
A
LYS
59
HELX_P
A
LEU
67
A
LEU
68
1
3
10
disulf
2.031
A
CYS
11
A
SG
CYS
12
1_555
A
CYS
36
A
SG
CYS
37
1_555
disulf
2.020
A
CYS
12
A
SG
CYS
13
1_555
A
CYS
52
A
SG
CYS
53
1_555
CHEMOATTRACTANT
CHEMOATTRACTANT, CYTOKINE
CCL2_HUMAN
UNP
1
1
P13500
MKVSAALLCLLLIAATFIPQGLAQPDAINAPVTCCYNFTNRKISVQRLASYRRITSSKCPKEAVIFKTIVAKEICADPKQ
KWVQDSMDHLDKQTQTPKT
24
99
1DOL
1
76
P13500
A
1
2
77
3
anti-parallel
anti-parallel
A
GLU
50
A
GLU
51
A
ALA
53
A
ALA
54
A
ALA
40
A
ALA
41
A
THR
45
A
THR
46
A
LEU
25
A
LEU
26
A
ILE
31
A
ILE
32
98
I 41 2 2